Clarisa Gracia

Clarisa Gracia has led clinical research on oocyte cryopreservation outcomes in cancer patients, demonstrating that emergency fertility preservation with controlled ovarian stimulation is safe and effective even with compressed timelines before cancer treatment initiation. Her work on GnRH agonist co-treatment for ovarian protection during chemotherapy has informed clinical practice guidelines on gonadal shielding strategies. Her longitudinal studies of reproductive outcomes in cancer survivors have provided the evidence base for counseling young cancer patients about their fertility prospects.